science
plus
.abes.fr
|
explorer
À propos de :
http://hub.abes.fr/oup/periodical/annonc/2007/volume_18/issue_2/w
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
bibo:Issue
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
work
Issue
New Facet based on Instances of this Class
Attributs
Valeurs
type
work
Issue
Is Part Of
http://hub.abes.fr/oup/periodical/annonc/2007/volume_18
has manifestation of work
http://hub.abes.fr/oup/periodical/annonc/2007/volume_18/issue_2/m/web
http://hub.abes.fr/oup/periodical/annonc/2007/volume_18/issue_2/m/print
Date Copyrighted
2007
Rights
© 2006 European Society for Medical Oncology
© 2007 European Society for Medical Oncology
issue
2
is
Is Part Of
of
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
Prognostic significance of stromal versican expression in human endometrial cancer
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
Suicide and cancer: a gender-comparative study
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients?
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery
Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix
Dietary intake of fruit and vegetable and lung cancer risk: a case-control study in Harbin, northeast China
Reply to the article ‘Hepatitis C virus (HCV) infection and MALT-type ocular adnexal lymphoma (OAL)’ by P. Arnaud, M.-C. Escande, M. Lecuit et al. (Ann Oncol doi:10.1093/annonc/mdl369)
Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged ≥70 years with advanced ovarian cancer—a study by the AGO OVAR Germany
in this issue
International Association for Hospice and Palliative Care list of essential medicines for palliative care
Follow-up of successfully treated testicular cancer patients: consequences of the metabolic syndrome
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors
Phase II studies of anticancer chemotherapy: indirect evidence of poor quality
Second consensus on medical treatment of metastatic breast cancer
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
The cost-effectiveness of bisphosphonates in metastatic breast cancer: letter to the editor in response to Botteman et al. 2006
Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)
Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer
What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?
Components of the metabolic syndrome in long-term survivors of testicular cancer
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
Rasburicase-induced fatal respiratory arrest?
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata